{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:35:10Z","timestamp":1784086510922,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ygyno.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:41:37Z","timestamp":1697236897000},"page":"102-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2\/3"],"prefix":"10.1016","volume":"178","author":[{"given":"Chad M.","family":"Michener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"AlHilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Beffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Debernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Brainard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Plesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome L.","family":"Belinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia L.","family":"Trimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2023.10.003_bb0005","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"6","key":"10.1016\/j.ygyno.2023.10.003_bb0010","first-page":"962","article-title":"Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence","volume":"92","author":"Modesitt","year":"1998","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.10.003_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2017.10.029","article-title":"Vulvar intraepithelial neoplasia: risk factors for recurrence","volume":"148","author":"Satmary","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2023.10.003_bb0020","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/IGC.0b013e3182a57fd6","article-title":"Clinical characteristics associated with development of recurrence and progression in usual-type vulvar intraepithelial neoplasia","volume":"23","author":"van Esch","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2023.10.003_bb0025","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer","volume":"18","author":"Efferth","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2023.10.003_bb0030","author":"Health Organization W"},{"issue":"6","key":"10.1016\/j.ygyno.2023.10.003_bb0045","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0035-9203(92)90137-2","article-title":"Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria","volume":"86","author":"Hein","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ygyno.2023.10.003_bb0050","series-title":"WHO Guidelines for malaria - 25 November 2022","year":"2022"},{"issue":"9430","key":"10.1016\/j.ygyno.2023.10.003_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(04)16680-4","article-title":"Antimalarial combinations","volume":"364","author":"Kremsner","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ygyno.2023.10.003_bb0060","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1128\/AAC.46.12.3933-3939.2002","article-title":"Intramuscular bioavailability and clinical efficacy of Artesunate in Gabonese children with severe malaria","volume":"46","author":"Nealon","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ygyno.2023.10.003_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ygyno.2023.10.003_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.828856","article-title":"Repurposing artemisinin and its derivatives as anticancer drugs: a chance or challenge?","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.10.003_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/microorganisms8010085","article-title":"The use of antimalarial drugs against viral infection","volume":"8","author":"D\u2019Alessandro","year":"2020","journal-title":"Microorganisms."},{"issue":"5","key":"10.1016\/j.ygyno.2023.10.003_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1055-9965.EPI-12-0073","article-title":"Circulating biomarkers of Iron storage and clearance of incident human papillomavirus infection","volume":"21","author":"Siegel","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"23","key":"10.1016\/j.ygyno.2023.10.003_bb0085","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1158\/0008-5472.CAN-05-1216","article-title":"Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo","volume":"65","author":"Disbrow","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2023.10.003_bb0090","first-page":"57","article-title":"The role of human papillomavirus in nongenital cancers","volume":"63","author":"Zandberg","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2023.10.003_bb0095","series-title":"A Pharmacokinetic and Pharmacodynamic Study of Intravenous vs Oral Artesunate in Uncomplicated Falciparum Malaria","first-page":"123","volume":"45","author":"Batty","year":"1998"},{"issue":"1","key":"10.1016\/j.ygyno.2023.10.003_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2023.10.003_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A randomised, double blind, placebo-controlled pilot study of Oral Artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine."},{"issue":"2","key":"10.1016\/j.ygyno.2023.10.003_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.ygyno.2023.10.003_bb0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","article-title":"A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies","volume":"81","author":"Deeken","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.10.003_bb0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2019.12.035","article-title":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3)","volume":"157","author":"Trimble","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2023.10.003_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1158\/1940-6207.CAPR-22-0086","article-title":"Vulvar cancer incidence in the United States and its relationship to human papillomavirus vaccinations, 2001\u20132018","volume":"15","author":"Berenson","year":"2022","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ygyno.2023.10.003_bb0130","series-title":"Addendum 1 Female Genital Grading Table for Use in Microbicide Studies Individual Signs\/Symptoms Parameter Grade 0 Normal Grade 1 Mild Grade 2 Moderate Grade 3 Severe Grade 4 Potentially Life-Threatening","article-title":"Division of aids table for grading the severity of adult and pediatric adverse events publish date","author":"Williams","year":"2004"},{"key":"10.1016\/j.ygyno.2023.10.003_bb0135","series-title":"Rapid Spontaneous Regression of Acute-Onset Vulvar Intraepithelial Neoplasia 3 in Young Women: A Case Series","author":"Stephenson","year":"2023"},{"issue":"3","key":"10.1016\/j.ygyno.2023.10.003_bb0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.ogx.0000201922.51030.ab","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"61","author":"Jones","year":"2006","journal-title":"Obstet. Gynecol. Surv."},{"issue":"12","key":"10.1016\/j.ygyno.2023.10.003_bb0145","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S1470-2045(14)70456-5","article-title":"Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial","volume":"15","author":"Tristram","year":"2014","journal-title":"Lancet Oncol."},{"issue":"10337","key":"10.1016\/j.ygyno.2023.10.003_bb0150","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(22)00469-X","article-title":"Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial","volume":"399","author":"Trutnovsky","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ygyno.2023.10.003_bb0155","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/AOG.0000000000002311","article-title":"Topical 5-fluorouracil for women with high-grade vaginal intraepithelial neoplasia","volume":"130","author":"Fiascone","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.10.003_bb0160","first-page":"702","article-title":"5-fluorouracil topical treatment of in situ vulvar cancer. A preliminary report","volume":"51","author":"Krupp","year":"1978","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2023.10.003_bb0165","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00007611-199007000-00010","article-title":"Treatment of extensive vulvar Condylomata Acuminata with topical 5-fluorouracil","volume":"83","author":"Krebs","year":"1990","journal-title":"South. Med. J."},{"issue":"4","key":"10.1016\/j.ygyno.2023.10.003_bb0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QAD.0b013e32835a9b16","article-title":"Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women","volume":"27","author":"Stier","year":"2013","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.ygyno.2023.10.003_bb0175","first-page":"147","article-title":"Precursor lesions of vulvar squamous cell carcinoma \u2013 histology and biomarkers: a systematic review","author":"Dasgupta","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823014944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:05:39Z","timestamp":1758773139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823014944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"alternative-id":["S0090825823014944"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.10.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2\/3","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}